According to MIT Technology Review, Altos Labs, a biological tech re-programmer, has reportedly attracted major investors such as CEO Jeff Bezos from Amazon and Yuri Milner, the Russian-Israeli billionaire.
The company is presently inviting some of the world’s top experts in the field of anti-aging research to join it with large salaries and to allow them full reign.
The richest guy in the world has previously invested in the development of anti-aging therapeutic systems, particularly in a San François-based biotech company called Unity Technologies in 2018.
One of the many scientists who come to board Altos is Juan Carlos Izpisúa Belmonte, a biotechnologist from the Salk Institute in La Jolla, California. In 2017, he started research on human/pig chimaera. He made waves.
Also joining the head of the Altos Scientific Advisory Council will be Shinya Yamanaka, a scientist and Nobel Prize winner for his study on the ageing reversal of cells.
Yamanaka stated to the technology review of MIT, “Even though many barriers need to be addressed, there is great promise.
